Back to the journal
Peptides
5 min read
Short answer. Enforcement discretion means HHS has said it does not intend to take action in a narrow set of cases. It is not a statute. It is not FDA approval. It does not put a peptide on the 503A bulks list. As of Oct 29, 2026.
Part of The Sommar Peptide Guide. The hub is HHS and 6 peptides: what changed.
The sentence that matters
On Oct 28, 2026, HHS filed a notice of availability for a draft policy, FR Doc. 2026-22192, docket HHS-OASH-2026-0496 [1]. The notice says HHS does not intend to take enforcement action against a state-licensed pharmacy, a federal facility, or a licensed physician compounding a drug product using a peptide bulk drug substance in Appendix A [1].
Read the limits inside that sentence.
It names three kinds of compounders. A website selling vials is not one of them.
It names peptides in an appendix. The policy lists six [2].
"Does not intend" is a statement about enforcement. It is not a finding that a peptide works.
The same notice says the draft does not establish any rights for any person and is not binding on HHS or the public [1].
What the phrase is not
People hear | The notice says |
|---|---|
It is legal now | HHS described when it does not intend to act [1] |
FDA approved it | Compounded drugs are not FDA-approved [1] |
It is on the pharmacy list | The 503A bulks list is still in rulemaking [1] |
Anyone can sell it | The sentence names licensed compounders [1] |
Compounded drugs are not reviewed by FDA for safety, effectiveness, or quality before they are marketed [1]. The policy document says the discretion applies when every listed condition is present, and that HHS may revisit the policy if a safety signal or a product-quality problem appears [2].
FAQ
Does enforcement discretion make a peptide legal for anyone to sell? No. The notice describes HHS enforcement against specific compounders, under conditions [1][2].
Is this a law Congress passed? No. It is a draft enforcement policy. The notice says it is not binding [1].
Sources
HHS. Notice of availability, Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. Docket HHS-OASH-2026-0496, FR Doc. 2026-22192. Filed Oct 28, 2026, 11:15 a.m. Publication date Oct 30, 2026. https://public-inspection.federalregister.gov/2026-22192.pdf
HHS. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances, including Appendices A and B. https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf
Sommar Club does not prescribe or sell BPC-157, TB-500, MOTS-c, epitalon, semax, or KPV. Education only. Not medical or legal advice. Policies change. Check the as-of date.
